MediWound Ltd (MDWD):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:MediWound Ltd (MDWD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9804
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:42
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MediWound Ltd (MediWound) is a biopharmaceutical company that on develops, manufactures and commercializes novel therapeutics based on its patented proteolytic enzyme technology. Its products address unmet needs in the areas of severe burns, chronic and other hard-to-heal wounds.The company’s first innovative biopharmaceutical product, NexoBrid is approved for removal of damaged or dead tissue, namely, eschar, in adults with deep partial and full-thickness thermal burns. MediWound has approval to market NexoBrid in the European Union, Israel and Argentina. The company sells NexoBrid in Europe, Israel through its commercial organization and in Argentina, through local distributor. MediWound is headquartered in Yavne, Israel.

MediWound Ltd (MDWD) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
MediWound Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MediWound Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
MediWound Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MediWound Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
MediWound Ltd, Medical Devices Deals, 2012 to YTD 2018 9
MediWound Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
MediWound Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
MediWound Raises US$20 Million In Venture Financing 11
Partnerships 12
MediWound Enters into Distribution Agreement with Holy Stone Healthcare 12
MediWound Enters Distribution Agreement with Avalon Pharma for NexoBrid 13
MediWound Enters Distribution Agreement With Genfa Medica For NexoBrid 14
Licensing Agreements 15
Kaken Pharma Enters into Licensing Agreement with MediWound 15
Equity Offering 16
MediWound Raises USD25.2 Million in Public Offering of Shares 16
MediWound Completes IPO For US$80.5 Million 18
Asset Transactions 20
MediWound to Sell NexoBrid 20
MediWound Ltd – Key Competitors 21
MediWound Ltd – Key Employees 22
MediWound Ltd – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Financial Announcements 24
Aug 07, 2018: MediWound Reports Second Quarter 2018 Financial Results 24
May 10, 2018: MediWound Reports First Quarter 2018 Financial Results 26
Mar 19, 2018: MediWound Announces Fourth Quarter And Fiscal Year 2017 Financial Results 28
Nov 16, 2017: MediWound Reports Third Quarter 2017 Financial Results 31
Aug 03, 2017: MediWound Reports Second Quarter 2017 Financial Results 33
May 08, 2017: MediWound Reports First Quarter 2017 Financial Results 35
Feb 21, 2017: MediWound Reports 2016 Fourth Quarter and Full Year Financial Results 37
Corporate Communications 39
Oct 25, 2017: MediWound Appoints Mr. Stephen T. Wills as Chairman to its Board of Directors 39
May 18, 2017: MediWound Announces Changes to its Board of Directors 40
Appendix 42
Methodology 42
About GlobalData 42
Contact Us 42
Disclaimer 42

List of Tables
MediWound Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
MediWound Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MediWound Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
MediWound Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MediWound Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
MediWound Ltd, Medical Devices Deals, 2012 to YTD 2018 9
MediWound Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
MediWound Raises US$20 Million In Venture Financing 11
MediWound Enters into Distribution Agreement with Holy Stone Healthcare 12
MediWound Enters Distribution Agreement with Avalon Pharma for NexoBrid 13
MediWound Enters Distribution Agreement With Genfa Medica For NexoBrid 14
Kaken Pharma Enters into Licensing Agreement with MediWound 15
MediWound Raises USD25.2 Million in Public Offering of Shares 16
MediWound Completes IPO For US$80.5 Million 18
MediWound to Sell NexoBrid 20
MediWound Ltd, Key Competitors 21
MediWound Ltd, Key Employees 22
MediWound Ltd, Subsidiaries 23

List of Figures
MediWound Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
MediWound Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
MediWound Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
MediWound Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
MediWound Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MediWound Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
MediWound Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MediWound Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
MediWound Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[MediWound Ltd (MDWD):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hawaiian Holdings, Inc.:企業の戦略・SWOT・財務分析
    Hawaiian Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Hawaiian Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Whiting Petroleum Corp (WLL):企業の財務・戦略的SWOT分析
    Whiting Petroleum Corp (WLL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • MallInckrodt Plc (MNK):製薬・医療:M&Aディール及び事業提携情報
    Summary Mallinckrodt Plc (Mallinckrodt) is develops, produces, commercializes, and distributes specialty pharmaceutical therapies and products. The company offers both branded and specialty generics for autoimmune and rare diseases in the specialty therapeutic areas of rheumatology, nephrology, neur …
  • Guangzhou Wondfo Biotech Co Ltd (300482):医療機器:M&Aディール及び事業提携情報
    Summary Guangzhou Wondfo Biotech Co Ltd (Wondfo) is a biological company that develops, manufactures and supplies rapid diagnostic reagents and related equipment. Its products include rapid quantitative test, immunofluorescent test system, glucose monitoring system, and raw materials. Wondfo also of …
  • Da Afghanistan Breshna Sherkat:企業の戦略的SWOT分析
    Da Afghanistan Breshna Sherkat - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Philips Healthcare-医療機器分野:企業M&A・提携分析
    Summary Philips Healthcare, formerly Philips Medical Systems, undertakes the manufacture and distribution of diagnostic imaging systems, healthcare information technology solutions, patient monitoring and cardiac devices. Philips Healthcare is a division of Royal Philips Electronics of the Netherlan …
  • PT Sun Life Financial Indonesia:企業の戦略・SWOT・財務情報
    PT Sun Life Financial Indonesia - Strategy, SWOT and Corporate Finance Report Summary PT Sun Life Financial Indonesia - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Stolt-Nielsen Ltd (SNI):石油・ガス:M&Aディール及び事業提携情報
    Summary Stolt-Nielsen Ltd (Stolt-Nielsen) is an integrated global transportation company, which provides bulk-liquid transportation, storage and distribution services. The company operates a fleet of deep-sea, regional, coastal and inland parcel tankers, to offers transportation services to the manu …
  • George Weston Limited:企業の戦略・SWOT・財務情報
    George Weston Limited - Strategy, SWOT and Corporate Finance Report Summary George Weston Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • U.S. Bancorp:戦略・SWOT・企業財務分析
    U.S. Bancorp - Strategy, SWOT and Corporate Finance Report Summary U.S. Bancorp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • TSUM Trading House:企業の戦略的SWOT分析
    TSUM Trading House - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Tapestry, Inc.:企業の戦略・SWOT・財務情報
    Tapestry, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tapestry, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Sembcorp Industries Ltd (U96):石油・ガス:M&Aディール及び事業提携情報
    Summary Sembcorp Industries Ltd (Sembcorp) is a diversified energy, water and marine company. It provides solutions across the energy and utilities value chain, with a focus on gas and power, renewables and environment, and merchant and retail sectors. The company carries out production and supply o …
  • CONSOL Energy Inc.:企業のM&A・事業提携・投資動向
    CONSOL Energy Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CONSOL Energy Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Xylem Inc (XYL):電力:M&Aディール及び事業提携情報
    Summary Xylem Inc (Xylem) is a water technology company. It designs, manufactures, and services engineered solutions ranging across a wide variety of applications. The company’s offerings address customer needs across the water cycle, from the delivery, measurement and use of drinking water to the c …
  • XTL Biopharmaceuticals Ltd (XTLB):企業の財務・戦略的SWOT分析
    Summary XTL Biopharmaceuticals Ltd (XTL) is a drug development company that focuses on the acquisition and development of late-stage pharmaceutical product candidates for the treatment of unmet clinical needs. The company’s pipeline products include hCDR1 peptide and recombinant human erythropoietin …
  • CVS Health Corporation:企業のM&A・事業提携・投資動向
    CVS Health Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CVS Health Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Diamond Offshore Drilling Inc (DO):石油・ガス:M&Aディール及び事業提携情報
    Summary Diamond Offshore Drilling Inc (Diamond Offshore) is an offshore oil and gas drilling company, which provides contract drilling services to the energy industry. It operates through a fleet of offshore drilling rigs comprising semisubmersibles, jack-ups, and dynamically positioned drillships. …
  • RED HAT, INC.:企業の戦略・SWOT・財務情報
    RED HAT, INC. - Strategy, SWOT and Corporate Finance Report Summary RED HAT, INC. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Kayson Inc:企業の戦略・SWOT・財務分析
    Kayson Inc - Strategy, SWOT and Corporate Finance Report Summary Kayson Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆